Find your next paid study

Barnet Dulaney Perkins Eye CentersNCT06953349

~$10 – $1,125

Tolerability of an Anesthesia-free Tonometer Tip

The purpose of this study is to compare the tolerability and comfort of 4 different prototype anesthesia-free tonometer tips with the standard tonometer tip in…

Glaucoma

Duke UniversityNCT06585423

~$10 – $6,250

Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)

A Randomized Controlled Trial Comparing Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT) in Reducing Intraocular Pressure in Open-Angle Glaucoma

This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Bo…

Medical University of South CarolinaNCT07408154

~$10 – $6,250

Phase 3

A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of the Bimatoprost Implant System (78 mcg) Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%,

This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in partici…

CataractGlaucomaOcular Hypertension

SpyGlass Pharma, Inc.NCT07218783

Eye DiseasesRetinal DiseaseGlaucoma+1 more

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adu…

Duke UniversityNCT06841575

~$10 – $6,250

Ocular HypertensionPrimary Open Angle Glaucoma

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotens…

59th Medical WingNCT05844384

~$10 – $7,500

Phase 3

A Randomized, Double-blind, Multiple Dose, Parallel-group, Two-arm, Multicenter, Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® (Bimatoprost Ophthalmic Solution) 0.01% in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioeq…

Glaucoma, Open-AngleOcular Hypertension

Amneal Pharmaceuticals, LLCNCT05401357

Glaucoma Laser Assessment of Stability and Sustainability: Evaluating Long-Term Stability and Retreatment Efficacy of DSLT in Patients With Ocular Hypertension, Glaucoma Suspects, and Mild/Moderate POAG.

The GLASS Study is designed to help researchers learn whether repeating a non-invasive laser treatment called DSLT (Direct Selective Laser Trabeculoplasty) can…

Glaucoma

Twin Cities Eye ConsultantsNCT06963684

~$10 – $7,500

Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Medication Burden in Medically Controlled Patients With Ocular Hypertension or Primary Open Angle Glaucoma

This is a prospective, single arm, open label study conducted at a single site to evaluate the efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in red…

Primary Open Angle GlaucomaOcular Hypertension

The Eye Institute of West FloridaNCT07390890

~$10 – $1,125

The Effects of Temporary Tube Ligation in Ahmed Glaucoma Valve Surgery

The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more…

Glaucoma EyeAhmed Glaucoma Valve Implantation

Washington University School of MedicineNCT05685485

~$10 – $750

CLAD Deconvolved PERG Responses in Glaucoma Patients

Glaucoma is a progressive disease resulting in blindness. Determining the onset of the disease is critical so patients may obtain treatment to preserve useful …

Glaucoma, Suspect

Open-angle GlaucomaOcular Hypertension

Jorvec Corp.NCT06388096

Phase 1

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint Comparing Generic Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® (Bimatoprost Ophthalmic Solution) 0.01% in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

A randomized, double-blind, parallel-group, two-arm, multiple dose, multicenter, clinical endpoint bioequivalence study